Substance use treatment clinician attitudes to care for chronic disease health risk behaviours and associations of attitudes with care provision.
attitudes
chronic illness
modifiable health risk behaviours
preventive care
substance use treatment settings
Journal
Drug and alcohol review
ISSN: 1465-3362
Titre abrégé: Drug Alcohol Rev
Pays: Australia
ID NLM: 9015440
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
05
05
2019
revised:
23
01
2020
accepted:
04
02
2020
pubmed:
23
2
2020
medline:
1
12
2020
entrez:
22
2
2020
Statut:
ppublish
Résumé
People who use substances have a high prevalence of modifiable chronic disease health risk behaviours. Preventive care to address such risks has not traditionally been provided during substance use treatment. This study aimed to assess clinicians' attitudes towards preventive care and their association with care provision. A cross-sectional study utilising computer-assisted telephone interviews was undertaken with clinicians (n = 54) of community-based substance use treatment services in one health district, Australia. Clinicians indicated their agreement with 10 attitudinal statements regarding their perceived role and self-efficacy in providing preventive care and perceptions of client interest in modifying behaviours. Logistic regression analyses examined the association between clinician attitudinal items and self-reported care provision. Fifty-four clinicians (74%) agreed to participate. The most positive attitudes were preventive care being part of their role (100%), and they have the knowledge and skills to provide preventive care (100%). The least favourable attitude was clients were interested in changing their health risk behaviours (60%). Clinicians who reported that preventive care left little time to undertake acute care were more likely to assess for smoking (OR 8.06 [95% CI 1.31, 49.46]) and less likely to provide brief advice for all risks combined (OR 0.11 [95% CI 0.02, 0.63]). Overall, clinicians reported positive attitudes regarding the preventive care provision for modifiable health risk behaviours in substance use treatment settings. Further research is required to investigate why, despite such positive attitudes, clinicians in substance use treatment settings do not routinely provide preventive care.
Banques de données
ANZCTR
['ACTRN12614000469617']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
232-237Informations de copyright
© 2020 Australasian Professional Society on Alcohol and other Drugs.
Références
Prochaska J, Delucchi K, Hall S. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. J Consult Clin Psychol 2004;72:1144-56.
Baca CT, Yahne CE. Smoking cessation during substance abuse treatment: what you need to know. J Subst Abuse Treat 2009;36:205-19.
Kelly PJ, Baker AL, Deane FP, Kay-Lambkin FJ, Bonevski B, Tregarthen J. Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment. Drug Alcohol Rev 2012;31:638-44.
Tremain D, Freund M, Wolfenden L et al. Modifiable health risk behaviours and attitudes towards behaviour change of clients attending community-based substance use treatment services. Drug Alcohol Rev 2017;36:369-77.
National Institute on Drug Abuse. Principles of Drug Addiction Treatment: A Research-Based Guide. Maryland, US: National Institute on Drug Abuse, 2012 Contract No. NIH Publication No. 12-4180.
New South Wales Health. HNE health drug and alcohol services plan 2007-2011. Hunter New England Health: New Lambton, 2007.
Tremain D, Freund M, Wye P et al. Provision of chronic disease preventive care in community substance use services: client and clinician report. J Subst Abuse Treat 2016;68:24-30.
Cookson C, Strang J, Ratschen E, Sutherland G, Finch E, McNeill A. Smoking and its treatment in addiction services: Clients' and staff behaviour and attitudes. BMC Health Serv Res 2014;14:304.
Knudsen HK. Implementation of smoking cessation treatment in substance use disorder treatment settings: a review. Am J Drug Alcohol Abuse 2017;43:215-225.
Knudsen HK, Studts JL. The implementation of tobacco-related brief interventions in substance abuse treatment: a national study of counselors. J Subst Abuse Treat 2010;38:212-9.
Knudsen HK, Studts CR, Studts JL. The implementation of smoking cessation counseling in substance abuse treatment. J Behav Health Serv Res 2012;39:28-41.
Laschober TC, Muilenburg JL, Eby LT. Factors linked to substance use disorder counselors' (non)implementation likelihood of tobacco cessation 5 A's, counseling, and pharmacotherapy. J Addict Behav Ther Rehabil 2015;4. https://doi.org/10.4172/2324-9005.1000134.
Fiore MJ, Jaén CR, Baker T. USDoHaH S, ed. Treating tobacco use and dependence: 2008 update Clinical practice guideline. Rockville, MD: Public Health Service, 2008.
Laws R, Kirby S, Davies G et al. "Should I and can I?": a mixed methods study of clinician beliefs and attitudes in the management of lifestyle risk factors in primary health care. BMC Health Serv Res 2008;8:44.
Bartlem K, Bowman J, Ross K et al. Mental health clinician attitudes to the provision of preventive care for chronic disease risk behaviours and association with care provision. BMC Psychiatry 2016;16:57.
Guydish J, Passalacqua E, Tajima B, Manser ST. Staff smoking and other barriers to nicotine dependence intervention in addiction treatment settings: a review. J Psychoactive Drugs 2007;39:423-33.
Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. US: Wiley & Sons; 2004. 392 p.
Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297-314 1p following 314.
Cane J, O'Connor D, Michie S. Validation of the theoretical domains framework for use in behaviour change and implementation research. Implemen Sci 2012;7:37.